Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1XNX

Crystal structure of constitutive androstane receptor

Summary for 1XNX
Entry DOI10.2210/pdb1xnx/pdb
Descriptorconstitutive androstane receptor, 16,17-ANDROSTENE-3-OL (3 entities in total)
Functional Keywordsnuclear receptor; crystal structure, ligand receptor-transcription regulation complex, ligand receptor/transcription regulation
Biological sourceMus musculus (house mouse)
Cellular locationNucleus: O35627
Total number of polymer chains2
Total formula weight59843.34
Authors
Fernandez, E. (deposition date: 2004-10-05, release date: 2005-01-04, Last modification date: 2024-10-30)
Primary citationShan, L.,Vincent, J.,Brunzelle, J.S.,Dussault, I.,Lin, M.,Ianculescu, I.,Sherman, M.A.,Forman, B.M.,Fernandez, E.
Structure of the murine constitutive androstane receptor complexed to androstenol; a molecular basis for inverse agonism
Mol.Cell, 16:907-917, 2004
Cited by
PubMed Abstract: The nuclear receptor CAR is a xenobiotic responsive transcription factor that plays a central role in the clearance of drugs and bilirubin while promoting cocaine and acetaminophen toxicity. In addition, CAR has established a "reverse" paradigm of nuclear receptor action where the receptor is active in the absence of ligand and inactive when bound to inverse agonists. We now report the crystal structure of murine CAR bound to the inverse agonist androstenol. Androstenol binds within the ligand binding pocket, but unlike many nuclear receptor ligands, it makes no contacts with helix H12/AF2. The transition from constitutive to basal activity (androstenol bound) appears to be associated with a ligand-induced kink between helices H10 and H11. This disrupts the previously predicted salt bridge that locks H12 in the transcriptionally active conformation. This mechanism of inverse agonism is distinct from traditional nuclear receptor antagonists thereby offering a new approach to receptor modulation.
PubMed: 15610734
DOI: 10.1016/j.molcel.2004.11.037
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.9 Å)
Structure validation

237735

數據於2025-06-18公開中

PDB statisticsPDBj update infoContact PDBjnumon